1800 202 8726
Prostate cancer diagnosis

PI-RADS 4 and Prostate MRI: — Do You Actually Need a Biopsy?

A PI-RADS 4 result is alarming to receive. It does not mean you definitely have cancer — but it means the question must be answered properly, and that usually requires a biopsy done the right way.

Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed September 2026

  • Not a diagnosis — PI-RADS 4 is a suspicion level from the MRI, not a confirmed cancer diagnosis. Only a biopsy confirms that.
  • Biopsy is usually recommended — At PI-RADS 4, most guidelines consider the level of suspicion high enough to warrant biopsy.
  • The type of biopsy matters — Targeted MRI-guided biopsy finds more significant cancers and fewer insignificant ones than random sampling.
  • Ask about targeted biopsy — Access is growing in India. It is worth asking your urologist whether it is available at your centre.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get this explained properly

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

A PI-RADS 4 score means the radiologist considers significant cancer likely in that part of the prostate. Most urologists will recommend a biopsy. The real question is not whether to have one, but what kind — a targeted MRI-guided biopsy is now recommended over standard random sampling by EAU and NCCN guidance.

What does your PI-RADS score actually mean?

PI-RADS stands for Prostate Imaging Reporting and Data System. It is a five-point scale that tells you how suspicious a lesion looks on a prostate MRI.

Scores of 1 and 2 mean significant cancer is considered unlikely. A score of 3 is uncertain — the MRI alone cannot give a confident answer. Scores of 4 and 5 mean significant cancer is considered likely or very likely.

The score describes MRI appearances, not pathology. Only a biopsy with tissue examination can confirm whether cancer is present.

What should I ask before a prostate biopsy?

  • Is a targeted MRI-guided biopsy available here?Targeted biopsy directs the needle to the exact lesion on the MRI rather than sampling the prostate at random.
  • Where exactly is the PI-RADS 4 lesion, and how large is it?Knowing the location and size helps you understand what is being targeted and compare it to any future imaging.
  • Should the MRI be reviewed by a second radiologist?MRI reporting quality varies between centres. A second read is reasonable if you are not at a high-volume uroradiology unit.
  • What is the plan if the biopsy comes back negative?A negative biopsy on a PI-RADS 4 lesion does not always close the question. Ask what follow-up is planned.
  • How does my PSA level and trend fit with this score?The MRI score and your PSA together give a fuller picture than either reading alone.

Still unclear?

Send your reports across and a specialist will walk you through what they mean — what is known, what is not, and what the options actually are.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

What is the difference between targeted and standard prostate biopsy?

Standard systematic biopsyTargeted MRI-guided biopsy
How the needle is guidedRandom pattern — typically 10 to 12 cores across the whole prostateDirected to the specific lesion identified on MRI
MRI required beforehandNoYes — essential
Detection of significant cancerMisses some; also finds insignificant cancers that may not need treatmentHigher rate of detection; fewer insignificant cancers found
Availability in IndiaWidely availableGrowing, mainly at larger centres
Current guideline preferenceOlder standardRecommended by EAU and NCCN current guidance

Can I avoid a prostate biopsy with PI-RADS 4?

Can I avoid the biopsy altogether?

Possibly in some situations, but not a decision to make without your urologist. Some low-risk presentations are managed with close MRI surveillance rather than immediate biopsy. At PI-RADS 4, most current guidelines consider the suspicion high enough to recommend biopsy rather than watch-and-wait. Bring this question directly to your treating team — the answer depends on your PSA level, lesion size, and other clinical features.

Does PI-RADS 4 mean I definitely have cancer?

No. It means the MRI appearance is suspicious enough that significant cancer is considered likely — but a meaningful proportion of PI-RADS 4 lesions turn out not to be clinically significant cancer when tissue is examined. The score is a risk indicator, not a diagnosis. Only a biopsy with tissue examination can answer the question definitively.

What is the difference between a fusion biopsy and a cognitive targeted biopsy?

Both aim the needle at the MRI-identified lesion rather than sampling randomly. A fusion biopsy overlays the MRI on a real-time ultrasound using software, tracking the needle precisely. A cognitive targeted biopsy means the urologist mentally maps the lesion and aims accordingly during the ultrasound — more experience-dependent and less reproducible. Both outperform random systematic biopsy. Ask which approach your centre offers.

What if the biopsy comes back negative?

A negative biopsy on a PI-RADS 4 lesion does not close the question. The needle can miss the lesion — which is one reason targeted biopsy reduces sampling error without eliminating it entirely. Your urologist will usually plan continued follow-up with repeat PSA measurement and a repeat MRI after an interval. Tell your team if the result does not fit with your PSA trend.

Is prostate MRI and targeted biopsy coordinated through CION?

CION coordinates diagnostic imaging through partner imaging centres. Prostate MRI quality depends heavily on the scanner and the radiologist's experience with prostate imaging — report quality varies significantly between centres. If you need a prostate MRI or a repeat scan before biopsy, ask your CION team which partner centre to use and confirm the report will come from a radiologist experienced in uroradiology.

Did you know?

Clinical trials including PRECISION and MRI-FIRST found that performing an MRI before biopsy, rather than proceeding immediately to systematic biopsy, detected more clinically significant cancers while reducing the number of men who underwent unnecessary procedures.

The European Association of Urology now recommends MRI before biopsy as the standard pathway for men with a raised PSA. This approach is still reaching many centres in India, which is why it is worth asking for by name.

Source: European Association of Urology Guidelines on Prostate Cancer, 2024; PRECISION trial, New England Journal of Medicine, 2018

Explore 71 more Understanding Your Biopsy and Whether You Need One topics

HUB — Does a Biopsy Spread Cancer? Myths and Evidence

HUB — What Is a Biopsy? Everything You Need to Know

All Understanding Your Biopsy and Whether You Need One →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

What is the difference between PI-RADS 3 and PI-RADS 4?

PI-RADS 3 is the uncertain score — the MRI alone cannot say whether significant cancer is likely or unlikely, and the biopsy decision depends heavily on your PSA, age, and clinical history. PI-RADS 4 moves into 'likely' territory, and most current guidelines treat it as a strong indication for biopsy. The step between 3 and 4 reflects a meaningful shift in the radiologist's confidence based on specific features visible on the scan.

How reliable is a prostate MRI?

Prostate MRI is significantly more accurate at identifying clinically significant cancers than older approaches — but its reliability depends on the scanner strength and, critically, the experience of the radiologist reporting it. A PI-RADS score from a radiologist who regularly reads prostate MRI is more dependable than one from a general radiology practice. If you have doubts about where your scan was reported, a second radiological opinion on the existing images is reasonable before proceeding.

What should I expect at a targeted prostate biopsy?

A targeted prostate biopsy is usually performed under local anaesthetic as a day procedure. The urologist uses an ultrasound probe to visualise the prostate, then guides the biopsy needle to the area identified on your MRI. You may feel pressure and some discomfort. There is a small risk of bleeding and infection; your team will give you antibiotics and tell you what symptoms need urgent attention. Most men go home the same day.

Does a positive biopsy result determine my treatment?

The biopsy result shapes the conversation — it does not dictate a single treatment. A positive biopsy tells the team the grade of the cancer, described as the Gleason score or Grade Group, and that grade drives the treatment options, not the PI-RADS score alone. Some lower-grade cancers found on targeted biopsy are suitable for active surveillance rather than immediate intervention. Your urologist will explain the options specific to your result.

How soon after the MRI should the biopsy be done?

There is no single rule, but the MRI should be recent enough that the prostate has not changed significantly — most centres aim to perform the biopsy within a few months of the scan. If there has been a prostate infection, procedure, or inflammation recently, your urologist may ask you to wait before biopsying to ensure accurate results. Ask your team when the scan was done and whether the timing is appropriate for the planned procedure.

If I want a second opinion on the MRI, do I need to have the scan repeated?

Usually not. A second radiological opinion is done on the existing images — not a new scan. MRI images are stored digitally and can be shared with another radiologist without repeating the procedure or the radiation exposure. What you are requesting is a second interpretation by someone with specific prostate MRI expertise. This is different from repeating the scan itself, which is rarely needed unless the original study was technically inadequate.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation